JPRN-jRCT2031210095暂停未知
Special use results survey: Spikevax Intramuscular Injection (previously COVID-19 Vaccine Moderna Intramuscular Injection) for subjects with underlying disease considered to be at high risk for severe illness, Acute phase safety surveillance (COVID-19)
Contact for Clinical Trial Information0 个研究点目标入组 0 人开始时间: 2021年5月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 暂停
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1. The participant is capable of understanding the contents of the investigation, recording his/her own symptoms in the health observation diary, and has obtained written consent to participate in the investigation from the vaccinee himself/herself (If minor, parent or legal guardian).
- •2. The participant has an underlying disease at the time of this drug vaccination that is considered to pose a high risk of aggravation of COVID-19.
排除标准
- •1. The subject has any contraindication to this drug.
研究者
相似试验
进行中（未招募）
不适用
ong-Term Follow-up Survey of COVID-19 Vaccine after vaccinatioJPRN-jRCT2031210168Contact for Clinical Trial Information8,538
尚未招募
不适用
Intramuscular glutathione as a systemic whitening agentPACTR201907742980888Sohag University Hospital30
招募中
3 期
To check the efficiency of two different routes (into the vein and into the muscle) of a medicine that will reduce swelling, pain and improve mouth opening after wisdom tooth removal. The medicine is dexamethasone and it reduces signs of inflammation.CTRI/2018/10/016164Mehul Saha
已完成
2 期
Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their InfantsRespiratory Syncytial Virus InfectionsNCT04126213GlaxoSmithKline534
招募中
1 期
Safety and efficacy evaluation of using natural killer cells to treat patients with recurrent and refractory high-risk neuroblastomaIRCT20170122032121N8Kian immune cell company10